English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

P243 Introduction: Extracorporeal Membrane Oxygenation,  or ECMO, provides cardiopulmonary support in critically ill patients  with reversible cardiac or respiratory disease processes. Neurologic  sequelae after ECMO have been well-studied in infants, but have not  been evaluated in adults. We investigated the incidence of focal  neurologic deficits in adults after global hypoxia-ischemia and ECMO as  reported by the survivors or as seen on physical examination of the  survivors.Methods: We performed a retrospective analysis of  all adult patients who received ECMO urgently between 12/95 and 1/99.  Fifty-nine percent of the survivors were contacted to participate in a  telephone survey regarding neurologic symptoms and quality of life  measures, including a Barthel Index. One survivor declined to  participate.Results: During the time period of 12/95 to  1/99, 86 adult patients received ECMO urgently at the University of  Michigan, 42 patients survived the hospitalization, and 44 patients  died. Of the 42 survivors, 7 were lost to followup, and 8 died at a  later date, with a mean length of survival after the ECMO  hospitalization of 17 months. The mean age of the ECMO survivors was 38  (18–72), racial distribution was 66% white, 27% black, and 7%  unknown or other. The survivors were 58% male and 42% female.  Underlying diagnoses requiring ECMO support were 85% respiratory, and  15% cardiac. Average length of followup was 36.5 months. Of those  contacted, 39% reported at least one neurologic symptom, moderately to  severely disabling, that was new since the hospitalization during which  ECMO occurred. Those symptoms are as follows: 13% unilateral weakness  in face and/or body, 13% difficulty with language, 17% difficulty  walking, and 9% blurred or double vision. All patients reported a  completely independent Barthel Index score.Conclusions: A  significant proportion of adult survivors of global hypoxia-ischemia  and ECMO report neurologic deficits that are at least moderately  disabling which are new since receiving ECMO. Of these deficits,  problems with ambulation were the most common. Physical examinations  are planned to further investigate these findings.

Focal Neurologic Deficits in Adults After Global Hypoxia-Ischemia and Extracorporeal Membrane Oxygenation